Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar falls on Biden transition, vaccine hopes; kiwi soars

Tue, 24th Nov 2020 12:09

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E

By Saikat Chatterjee

LONDON, Nov 24 (Reuters) - The Australian dollar rose to a
two-and-a-half-month high and the euro gained on Tuesday as U.S.
President Donald Trump accepted the transition to a Joseph Biden
presidency, which may include former Federal Reserve Chair Janet
Yellen as Treasury secretary.

Appetite for riskier assets was evident across the board.
Stocks and oil rose as progress made on COVID-19 vaccines, which
had underpinned Wall Street overnight, boosted optimism about a
quicker revival for the global economy.

Trump acknowledged the head of the General Services
Administration should go ahead with a transition to a government
led by President-elect Biden, despite plans to continue with
legal challenges.

Democratic allies to the Biden campaign said Yellen is
expected to be nominated to become Treasury Secretary. She has
called for increased government spending to lift the economy out
of a coronavirus-induced recession.

"That should be a positive appointment from the market’s
point of view, as she is expected to pursue conventional
policies," Commerzbank strategists said in a daily note.

"And as far as the fiscal package is concerned, she is
likely to listen to the Fed's demands and try and push a package
as much as possible."

Yellen has called for more fiscal spending to revive an
economy wrecked by the coronavirus pandemic. She would be the
first person to head the Treasury, the Fed and the White House
Council of Economic Advisers.

In contrast, U.S. Treasury Secretary Steven Mnuchin last
week let some of the Fed's lending programmes expire at the end
of this year, opening a feud with the central bank, which said
those emergency facilities are important to support the economy.

Against a basket of other major currencies, the
dollar weakened 0.4% to 92.13, just above Monday's 92.013, the
lowest in nearly three months.

The Australian dollar climbed 0.9% to $0.7367. The
euro gained 0.4% at $1.1894.

The euro's gains will be a concern for policymakers at
December's meeting of the European Central Bank. German Ifo data
and PMI surveys showed the European economy is struggling amid
lockdowns to slow a second wave of coronavirus
infections.

The dollar also struggled after AstraZeneca said its
COVID-19 vaccine could be about 90% effective and it would
prepare to submit data to authorities around the world,
increasing demand for risky assets.

The New Zealand dollar rose as much as 1% to a
two-year high of $0.6985, after the country's government sought
advice from the central bank on how it could help stabilise
property prices, prompting investors to unwind some bets of more
easing.

Elsewhere, cryptocurrency Bitcoin scaled a near
three-year peak of $19,000.

(Reporting by Saikat Chatterjee; Additional reporting by
Hideyuki Sano in Tokyo; editing by Kirsten Donovan, Larry King)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.